Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
Clinical trial NCT04893941 · COMPLETED
Trial details
- NCT number
- NCT04893941
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-21
- Primary completion
- 2021-01-22
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.